- Home
- RGR vs SVRA Comparison
RGR vs SVRA Comparison
Compare RGR & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- SVRA
- Stock Information
- Founded
- RGR 1949
- SVRA 2007
- Country
- RGR United States
- SVRA United States
- Employees
- RGR N/A
- SVRA N/A
- Industry
- RGR Ordnance And Accessories
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- SVRA Health Care
- Exchange
- RGR Nasdaq
- SVRA Nasdaq
- Market Cap
- RGR 553.4M
- SVRA 527.2M
- IPO Year
- RGR N/A
- SVRA N/A
- Fundamental
- Price
- RGR $34.97
- SVRA $3.16
- Analyst Decision
- RGR
- SVRA Buy
- Analyst Count
- RGR 0
- SVRA 7
- Target Price
- RGR N/A
- SVRA $5.57
- AVG Volume (30 Days)
- RGR 213.4K
- SVRA 1.3M
- Earning Date
- RGR 07-30-2025
- SVRA 08-13-2025
- Dividend Yield
- RGR 2.01%
- SVRA N/A
- EPS Growth
- RGR N/A
- SVRA N/A
- EPS
- RGR 0.35
- SVRA N/A
- Revenue
- RGR $536,291,000.00
- SVRA N/A
- Revenue This Year
- RGR N/A
- SVRA N/A
- Revenue Next Year
- RGR $2.58
- SVRA N/A
- P/E Ratio
- RGR $100.62
- SVRA N/A
- Revenue Growth
- RGR 3.31
- SVRA N/A
- 52 Week Low
- RGR $31.64
- SVRA $1.89
- 52 Week High
- RGR $42.76
- SVRA $4.70
- Technical
- Relative Strength Index (RSI)
- RGR 54.71
- SVRA 71.42
- Support Level
- RGR $33.70
- SVRA $2.92
- Resistance Level
- RGR $34.65
- SVRA $3.28
- Average True Range (ATR)
- RGR 0.70
- SVRA 0.21
- MACD
- RGR 0.18
- SVRA 0.04
- Stochastic Oscillator
- RGR 98.61
- SVRA 85.88
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.